PCM
BIVIW

Prelude Capital Management’s BioVie Inc Warrant BIVIW Stock Holding History

Prelude Capital Management’s Portfolio BIVIW Stock Details BIVIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$84K Hold
186,621
– – 0.01% 1135
2026
Q1 		$57.9K Hold
186,621
– – ﹤0.01% 1116
2025
Q4 		$48K Sell
186,621
-106,815
-36% -$35K ﹤0.01% 1239
2025
Q3 		$132K Buy
+293,436
New +$119K 0.01% 1019

Other funds holding BIVIW

DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $551M AUM 34.68% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
MA
MYDA Advisors Woodmere, New York $672M AUM 71.14% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return
TSS
Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Prelude Capital Management's BIVIW Position: Q2 2026 in Review

Prelude Capital Management held its BioVie Inc Warrant (BIVIW) position steady in Q2 2026 at 186,621 shares worth $84K. The position accounts for 0.01% of the portfolio, ranked #1135.

Prelude Capital Management first reported a position in BIVIW in Q3 2025 and has held it in 4 quarters since. The position peaked at $132K in Q3 2025. 8 funds tracked by Wall St. Rank hold BIVIW as of Q2 2026.

  • Prelude Capital Management held 186,621 shares of BioVie Inc Warrant worth $84K as of Q2 2026.
  • Prelude Capital Management left its BioVie Inc Warrant share count unchanged in Q2 2026.
  • BioVie Inc Warrant made up 0.01% of Prelude Capital Management's portfolio in Q2 2026, its #1135 holding.
  • Prelude Capital Management first reported a position in BioVie Inc Warrant in Q3 2025 and has held it in 4 quarters since.
  • Prelude Capital Management's BioVie Inc Warrant position peaked at $132K in Q3 2025.
  • 8 funds tracked by Wall St. Rank held BioVie Inc Warrant as of Q2 2026.

Based on Prelude Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.